Bristol-Myers Squibb Coverage Initiated at Credit Suisse (BMY)
Stock analysts at Credit Suisse assumed coverage on shares of Bristol-Myers Squibb (NYSE:BMY) in a report issued on Tuesday, TheFlyOnTheWall.com reports. The firm set an “outperform” rating on the stock.
BMY has been the subject of a number of other recent research reports. Analysts at Zacks reiterated an “underperform” rating on shares of Bristol-Myers Squibb in a research note to investors on Thursday, October 3rd. They now have a $43.00 price target on the stock. Separately, analysts at TheStreet reiterated a “buy” rating on shares of Bristol-Myers Squibb in a research note to investors on Wednesday, October 2nd. Finally, analysts at TheStreet reiterated a “buy” rating on shares of Bristol-Myers Squibb in a research note to investors on Tuesday, September 17th. Two research analysts have rated the stock with a sell rating, five have given a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $46.64.
Shares of Bristol-Myers Squibb (NYSE:BMY) traded down 0.89% during mid-day trading on Tuesday, hitting $46.60. 6,375,498 shares of the company’s stock traded hands. Bristol-Myers Squibb has a 1-year low of $30.64 and a 1-year high of $49.57. The stock has a 50-day moving average of $44.2 and a 200-day moving average of $43.69. The company has a market cap of $76.719 billion and a price-to-earnings ratio of 57.41.
Bristol-Myers Squibb (NYSE:BMY) last posted its quarterly earnings results on Thursday, July 25th. The company reported $0.44 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.45 by $0.01. The company had revenue of $4.05 billion for the quarter, compared to the consensus estimate of $4.07 billion. During the same quarter in the prior year, the company posted $0.48 earnings per share. The company’s quarterly revenue was down 8.9% on a year-over-year basis. On average, analysts predict that Bristol-Myers Squibb will post $1.74 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Friday, November 1st. Shareholders of record on Friday, October 4th will be paid a dividend of $0.35 per share. This represents a $1.40 annualized dividend and a dividend yield of 3.00%. The ex-dividend date is Wednesday, October 2nd.
Bristol-Myers Squibb Company (NYSE:BMY) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.